Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check4 days agoChange DetectedAdds recruitment status notice and several user-facing help sections (How to Read a Study Record, Common Questions, How to Join a Study) to improve participation and understanding. Standardizes the Intervention/Treatment label and updates the site's revision to v3.6.0.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5. This reflects a small platform update with no changes to study information.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a newer version of the study record. This reflects non-substantive edits or metadata updates to the page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the page's metadata. This reflects a small, non-substantive update to the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page's revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check82 days agoChange DetectedThe record was updated in 2024 with a new last update date and QC status; no changes to the core study design, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.